Create Account | Sign In: Author or Forum

Search Symptoms

Medical Specialty >> Oncology

As Mammograms Became Widespread, Breast Tumor Size Shrank

9:00 AM CDT. Read article More Oncology News


Hydrochlorothiazide Tied to Non-Melanoma Skin Cancer Risk

12:00 PM CDT. Dose-response association seen for basal cell and especially squamous cell carcinoma


February 2018 Briefing - Hematology & Oncology

March 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.


Robert L. Coleman, MD's avatarRucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

Elizabeth M. Swisher, MD's avatarCharacterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib

Elizabeth M. Swisher, MD. Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…

Bert Vogelstein, MD's avatarBert Vogelstein explains cancer and the unavoidable replicative mutations

Bert Vogelstein, MD. Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…


Tamer M. Fouad, M.D.'s avatar

Breast cancer

By Tamer M. Fouad, M.D. Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (11.9%…


RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

By MrRobin

Great articles. learnt a lot from it.